发明名称 ß2-OXO-1-PYRROLIDINDERIVATE UND IHRE PHARMAZEUTISCHE VERWENDUNGß
摘要 <p>A compound selected from (2S)-2-Ä(4S)-4-(2,2-difluorovinyl)-2-oxopyrrolidinylÜbutanamide or a pharmaceutically acceptable salt thereof. <??>The compounds of the invention are particularly suited for treating neurological disorders such as epilepsy.</p>
申请公布号 AT325093(T) 申请公布日期 2006.06.15
申请号 AT20040007733T 申请日期 2001.02.21
申请人 UCB, S.A. 发明人 DIFFERDING, EDMOND;KENDA, BENOIT;LALLEMAND, BENEDICTE;MATAGNE, ALAIN;MICHEL, PHILIPPE;PASAU, PATRICK;TALAGA, PATRICE
分类号 C07D401/04;A61K31/4015;A61K31/4025;A61K31/41;A61K31/4178;A61K31/4188;A61K31/4192;A61K31/4196;A61K31/422;A61K31/4245;A61K31/427;A61K31/433;A61K31/4439;A61K31/497;A61K31/506;A61K31/541;A61P9/00;A61P9/06;A61P9/10;A61P11/00;A61P11/06;A61P21/00;A61P25/00;A61P25/04;A61P25/06;A61P25/08;A61P25/14;A61P25/16;A61P25/20;A61P25/22;A61P25/24;A61P25/28;A61P25/30;A61P27/16;A61P37/08;C07B61/00;C07C237/06;C07C237/12;C07D207/26;C07D207/27;C07D207/273;C07D207/277;C07D307/33;C07D401/06;C07D403/04;C07D403/06;C07D403/12;C07D405/04;C07D409/04;C07D413/04;C07D417/04;C07D495/04;(IPC1-7):C07D207/27;A61K31/401 主分类号 C07D401/04
代理机构 代理人
主权项
地址